Home Tags Anti-CD3

Tag: anti-CD3

Memorial Sloan Kettering Research Building

Memorial Sloan-Kettering Agrees to Use New Technology for Neuroblastoma Research

Memorial Sloan-Kettering Cancer Center has agreed to use to Sutro Biopharma's proprietary cell-free protein synthesis technology to produce bispecific antibodies that were discovered in the center's clinic for the treatment of neuroblastoma in children.